Navigation Links
MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
Date:2/28/2011

aine in the United States estimated at over $20 billion annually.

About MAP Pharmaceuticals MAP Pharmaceuticals is an emerging biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.  Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com

Forward-Looking StatementsIn addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the development and regulatory approval process for the Company's LEVADEX product candidate. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, available at http://edgar.sec.gov.   CONTACTS: Nicole Foderaro


'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
2. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
3. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
5. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
6. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
8. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
9. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
10. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
11. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... SAN DIEGO , Sept. 16, 2014 /PRNewswire/ ... acquired enzastaurin, a late-stage oncology drug, from Eli ... rights to develop, manufacture and commercialize enzastaurin globally, ... rights, data, and information. Lilly ... in Phase 2 and Phase 3 clinical trials ...
(Date:9/16/2014)...  Decision Resources Group finds that the rheumatoid arthritis (RA) disease-modifying ... over $18.2 billion in 2023 in the United States ... , Italy , Spain , ... . TNF-alpha inhibitors will remain the leading drug class in ... will be constrained and patient shares will decline due to the ...
(Date:9/16/2014)... , Sept. 16, 2014   HemCon Medical ... of TriStar Wellness Solutions(R), Inc. (OTCQB: ... advanced medical products, announced today that the revenue ... by 39 percent, and microdispersed oxidized cellulose raw ... 2014.  Overall, TWSI expects third quarter revenues to ...
Breaking Medicine Technology:Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 2HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 3HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues 4
... April 26 Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical ... treatment of cancer, today announced that it will host a conference call ... Wednesday, May 5, 2010 , at 8:30 AM ET . , ... To participate in the conference ...
... , April 26 Cornerstone Therapeutics Inc. (Nasdaq: ... developing and commercializing significant products primarily for the respiratory and ... call at 8:00 AM ET on Tuesday, ... the quarter ended March 31, 2010 .  Management will ...
Cached Medicine Technology:Micromet to Report First Quarter 2010 Financial Results on May 5 2Cornerstone Therapeutics to Host First Quarter 2010 Conference Call 2Cornerstone Therapeutics to Host First Quarter 2010 Conference Call 3
(Date:9/17/2014)... Tampa, FL (PRWEB) September 17, 2014 Tina ... ), is finishing up her chemotherapy but not her fight ... up for the Komen Florida Suncoast “Race for the Cure” ... “I registered for the Komen Race for the Cure because ... breast cancer,” Griffin said. , As part of her efforts, ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Four ... eighth annual Wailea Tennis Fantasy Camp on ... Maui’s prestigious Wailea Tennis Club, with three-time grand slam ... returning to Wailea, Maui for her fifth year. , ... match play with Davenport, recently inducted into the International ...
(Date:9/17/2014)... September 17, 2014 A raucous childhood ... come together to form author Nancy Chovancek’s laughter-filled new ... is a collection of short stories that prove the ... fun. With a positive message of empowerment and resilience, ... is a proven author with two books under her ...
(Date:9/17/2014)... This September 18-20, 22 participating developmentally-disabled athletes ... three stage outdoor sporting event in non-profit World T.E.A.M. ... , Hosted at The Center for Discovery ... five participating teams coached by able-bodied athletes. For each ... provide expert guidance as well as technical assistance. Like ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 Lee ... settlement industry, will be appearing on The Balancing Act® ... two September episodes. , The segment will premiere on ... on 'The Balancing Act® airing on Lifetime Television®' with ... of Asset Funding Corp. for over a decade and ...
Breaking Medicine News(10 mins):Health News:Tina Griffin’s Fight Against Cancer Didn’t Stop With her Chemotherapy—Her Next Step Is to Run in the Suncoast ‘Race for the Cure’ Oct. 11 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 3Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge New York Includes Disabled Athletes 3Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2
... they sometimes use to compensate for the turbulence of ... They create an artificial star called a guide star ... turbulence. Lihong Wang, PhD, the Gene K. ... in St. Louis, has invented a guide star for ...
... Men looking for Valentine,s Day gifts are most concerned with ... that often means jewelry, according to a shopping behavior expert. ... they do -- and men want reassurance that their taste ... professor of hospitality management at the University of New Hampshire, ...
... SAN FRANCISCO (February 11, 2011) In a study ... Medicine,s (SMFM) annual meeting, The Pregnancy Meeting , in ... despite fetal pulmonary maturity, babies delivered at between 36 ... of neonatal morbidities. The American College of ...
... By E.J. Mundell HealthDay Reporter , THURSDAY, Feb. ... in scarlet, while Today show host Ann Curry ... show host Gayle King, sashayed in a cherry Donna Karan ... Taking part Wednesday night in the annual Red Dress Collection ...
... idea of image compression in computers. File extensions like ".jpg" or ... a more efficient format, reducing file size by a factor of ... quality. The full set of original pixel values would occupy too ... across networks. The brain is faced with a similar problem. ...
... developed by Dr Roger Bayston in the School of Clinical ... awarded an allied health professional training fellowship of almost 160,000 ... prevent bacterial infections associated with broken bones. Pins ... Up to 40 per cent of patients being treated in ...
Cached Medicine News:Health News:A guide star lets scientists see deep into human tissue 2Health News:A guide star lets scientists see deep into human tissue 3Health News:A guide star lets scientists see deep into human tissue 4Health News:A guide star lets scientists see deep into human tissue 5Health News:A guide star lets scientists see deep into human tissue 6Health News:Study finds even with fetal lung maturity, babies delivered prior to 39 weeks are at risk 2Health News:Stars Strut on the Runway for Women's Heart Health 2Health News:Stars Strut on the Runway for Women's Heart Health 3Health News:JPEG for the mind: How the brain compresses visual information 2Health News:Anti-bacterial collar to help mend broken bones 2
... Distriman is a ... that is designed to ... used with Gilson DistriTip ... polypropylene syringes with level ...
... lightweight and balanced for smooth, one-handed control. ... comfort, reducing fatigue in even the longest ... physician to easily steer the catheter through ... one finger. Reflexion's auto-lock technology keeps the ...
... performance technologies - Quantum™ LEAP® balloon ... - unite in the Quantum™ Maverick® ... dilatation force balloon with exceptional deliverability. ... Maverick® shaft technology improves trackability and ...
... Libert Coronary Stent System ... of lesion access and ... a low crossing profile, ... catheter, the performance of ...
Medicine Products: